BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 708263 O=C(NCc1ccccc1)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C25H22N6O3/c32-25(28-15-17-4-2-1-3-5-17)19-6-7-23-27-16-20(31(23)29-19)22-14-18-21(34-22)8-9-26-24(18)30-10-12-33-13-11-30/h1-9,14,16H,10-13,15H2,(H,28,32) WYBMLHRFXSOJGY-UHFFFAOYSA-N 358852 N-benzyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 4.40 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358852&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118227019 386398359 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708264 COCCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C22H24N6O4/c1-30-10-2-6-24-22(29)16-3-4-20-25-14-17(28(20)26-16)19-13-15-18(32-19)5-7-23-21(15)27-8-11-31-12-9-27/h3-5,7,13-14H,2,6,8-12H2,1H3,(H,24,29) MEENFNJMJCZNBC-UHFFFAOYSA-N 358853 N-(3-methoxypropyl)-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 3.80 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358853&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226887 386398360 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708265 CN(C)CCN(C)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H27N7O3/c1-27(2)8-9-28(3)23(31)17-4-5-21-25-15-18(30(21)26-17)20-14-16-19(33-20)6-7-24-22(16)29-10-12-32-13-11-29/h4-7,14-15H,8-13H2,1-3H3 FOYUODPUQZERHM-UHFFFAOYSA-N 358854 N-[2-(dimethylamino)ethyl]-N-methyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 88.0 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358854&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226896 386398361 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708266 CN1CCN(CC1)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H25N7O3/c1-27-6-8-29(9-7-27)23(31)17-2-3-21-25-15-18(30(21)26-17)20-14-16-19(33-20)4-5-24-22(16)28-10-12-32-13-11-28/h2-5,14-15H,6-13H2,1H3 GRIUCHRPBVVMKI-UHFFFAOYSA-N 358855 (4-Methylpiperazin-1-yl){3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo-[1,2-b]pyridazin-6-yl}methanone::US10214545, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 110 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358855&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226953 386398362 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708267 COCCN(C)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C22H24N6O4/c1-26(7-10-30-2)22(29)16-3-4-20-24-14-17(28(20)25-16)19-13-15-18(32-19)5-6-23-21(15)27-8-11-31-12-9-27/h3-6,13-14H,7-12H2,1-2H3 VOMKYFREVRKVTK-UHFFFAOYSA-N 358856 N-(2-methoxyethyl)-N-methyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 2.60 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358856&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226955 386398363 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708268 COCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-29-9-6-23-21(28)15-2-3-19-24-13-16(27(19)25-15)18-12-14-17(31-18)4-5-22-20(14)26-7-10-30-11-8-26/h2-5,12-13H,6-11H2,1H3,(H,23,28) WGGGLERYINLRRP-UHFFFAOYSA-N 358857 N-(2-methoxyethyl)-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 4.60 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358857&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226869 386398364 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708269 C[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-13(12-28)24-21(29)15-2-3-19-23-11-16(27(19)25-15)18-10-14-17(31-18)4-5-22-20(14)26-6-8-30-9-7-26/h2-5,10-11,13,28H,6-9,12H2,1H3,(H,24,29)/t13-/m1/s1 PVRBWFBXZIVHES-CYBMUJFWSA-N 358858 N-[(2R)-1-hydroxypropan-2-yl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 2.80 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358858&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126506660 386398365 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708270 C[C@@H](CO)NC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-13(12-28)24-21(29)15-2-3-19-23-11-16(27(19)25-15)18-10-14-17(31-18)4-5-22-20(14)26-6-8-30-9-7-26/h2-5,10-11,13,28H,6-9,12H2,1H3,(H,24,29)/t13-/m0/s1 PVRBWFBXZIVHES-ZDUSSCGKSA-N 358859 N-[(2S)-1-hydroxypropan-2-yl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 7.30 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358859&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226928 386398366 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708271 CN(C)CCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H27N7O3/c1-28(2)9-3-7-25-23(31)17-4-5-21-26-15-18(30(21)27-17)20-14-16-19(33-20)6-8-24-22(16)29-10-12-32-13-11-29/h4-6,8,14-15H,3,7,9-13H2,1-2H3,(H,25,31) XANSVPHMOYWUDL-UHFFFAOYSA-N 358860 N-[3-(dimethylamino)propyl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 1.50 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358860&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226903 386398367 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708272 CN(C)CCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H21N5O2/c1-24(2)11-5-10-21-20(26)15-8-9-19-22-13-16(25(19)23-15)18-12-14-6-3-4-7-17(14)27-18/h3-4,6-9,12-13H,5,10-11H2,1-2H3,(H,21,26) DDJUFZKSGQXYOQ-UHFFFAOYSA-N 358861 3-(1-Benzofuran-2-yl)-N-[3-(dimethylamino)propyl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 3.30 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358861&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226974 386398368 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708273 C[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O3/c1-11(10-23)20-18(24)13-6-7-17-19-9-14(22(17)21-13)16-8-12-4-2-3-5-15(12)25-16/h2-9,11,23H,10H2,1H3,(H,20,24)/t11-/m1/s1 CCGWYSCQCABNRE-LLVKDONJSA-N 358862 3-(1-Benzofuran-2-yl)-N-[(2R)-1-hydroxypropan-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 4.10 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358862&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126506376 386398369 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708274 COCCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O3/c1-25-10-4-9-20-19(24)14-7-8-18-21-12-15(23(18)22-14)17-11-13-5-2-3-6-16(13)26-17/h2-3,5-8,11-12H,4,9-10H2,1H3,(H,20,24) OGCODLLIZHFTLY-UHFFFAOYSA-N 358863 3-(1-Benzofuran-2-yl)-N-(3-methoxypropyl)imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 4.90 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358863&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226876 386398370 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708275 CC(C)[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-12(2)15(11-25)22-20(26)14-7-8-19-21-10-16(24(19)23-14)18-9-13-5-3-4-6-17(13)27-18/h3-10,12,15,25H,11H2,1-2H3,(H,22,26)/t15-/m0/s1 HQISLAYJOPDUTK-HNNXBMFYSA-N 358864 3-(1-Benzofuran-2-yl)-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]imidazo[1,2-b]-pyridazine-6-carboxamide::US10214545, Example 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 6.80 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358864&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126505992 386398371 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708276 O=C(NCc1ccccc1)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H16N4O2/c27-22(24-13-15-6-2-1-3-7-15)17-10-11-21-23-14-18(26(21)25-17)20-12-16-8-4-5-9-19(16)28-20/h1-12,14H,13H2,(H,24,27) OIHQAKBAJBCIMS-UHFFFAOYSA-N 358865 3-(1-Benzofuran-2-yl)-N-benzylimidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 5.20 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358865&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226966 386398372 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708277 COCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O3/c1-24-9-8-19-18(23)13-6-7-17-20-11-14(22(17)21-13)16-10-12-4-2-3-5-15(12)25-16/h2-7,10-11H,8-9H2,1H3,(H,19,23) OLVXJFKWUNVLLV-UHFFFAOYSA-N 358866 3-(1-Benzofuran-2-yl)-N-(2-methoxyethyl)imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 8.00 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358866&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226981 386398373 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708278 CN(Cc1ccccc1)C(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H18N4O2/c1-26(15-16-7-3-2-4-8-16)23(28)18-11-12-22-24-14-19(27(22)25-18)21-13-17-9-5-6-10-20(17)29-21/h2-14H,15H2,1H3 MOSBOQYSPFXZQT-UHFFFAOYSA-N 358867 3-(1-Benzofuran-2-yl)-N-benzyl-N-methylimidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 8.80 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358867&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226949 386398374 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708279 CN(C)CCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H19N5O2/c1-23(2)10-9-20-19(25)14-7-8-18-21-12-15(24(18)22-14)17-11-13-5-3-4-6-16(13)26-17/h3-8,11-12H,9-10H2,1-2H3,(H,20,25) JAFJCFZVEUTXGQ-UHFFFAOYSA-N 358868 3-(1-Benzofuran-2-yl)-N-[2-(dimethylamino)ethyl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 1.70 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358868&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226871 386398375 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708280 CC(C)[C@@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-12(2)15(11-25)22-20(26)14-7-8-19-21-10-16(24(19)23-14)18-9-13-5-3-4-6-17(13)27-18/h3-10,12,15,25H,11H2,1-2H3,(H,22,26)/t15-/m1/s1 HQISLAYJOPDUTK-OAHLLOKOSA-N 358869 3-(1-Benzofuran-2-yl)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]imidazo[1,2-b]-pyridazine-6-carboxamide::US10214545, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 1.30 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358869&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 91824175 386398376 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708281 O=C(NCc1ccccc1)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C25H22N6O3/c32-25(28-15-17-4-2-1-3-5-17)19-6-7-23-27-16-20(31(23)29-19)22-14-18-21(34-22)8-9-26-24(18)30-10-12-33-13-11-30/h1-9,14,16H,10-13,15H2,(H,28,32) WYBMLHRFXSOJGY-UHFFFAOYSA-N 358852 N-benzyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 5.60 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358852&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118227019 386398359 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708282 COCCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C22H24N6O4/c1-30-10-2-6-24-22(29)16-3-4-20-25-14-17(28(20)26-16)19-13-15-18(32-19)5-7-23-21(15)27-8-11-31-12-9-27/h3-5,7,13-14H,2,6,8-12H2,1H3,(H,24,29) MEENFNJMJCZNBC-UHFFFAOYSA-N 358853 N-(3-methoxypropyl)-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 7.00 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358853&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226887 386398360 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708283 CN(C)CCN(C)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H27N7O3/c1-27(2)8-9-28(3)23(31)17-4-5-21-25-15-18(30(21)26-17)20-14-16-19(33-20)6-7-24-22(16)29-10-12-32-13-11-29/h4-7,14-15H,8-13H2,1-3H3 FOYUODPUQZERHM-UHFFFAOYSA-N 358854 N-[2-(dimethylamino)ethyl]-N-methyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 140 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358854&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226896 386398361 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708284 CN1CCN(CC1)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H25N7O3/c1-27-6-8-29(9-7-27)23(31)17-2-3-21-25-15-18(30(21)26-17)20-14-16-19(33-20)4-5-24-22(16)28-10-12-32-13-11-28/h2-5,14-15H,6-13H2,1H3 GRIUCHRPBVVMKI-UHFFFAOYSA-N 358855 (4-Methylpiperazin-1-yl){3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo-[1,2-b]pyridazin-6-yl}methanone::US10214545, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 280 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358855&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226953 386398362 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708285 COCCN(C)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C22H24N6O4/c1-26(7-10-30-2)22(29)16-3-4-20-24-14-17(28(20)25-16)19-13-15-18(32-19)5-6-23-21(15)27-8-11-31-12-9-27/h3-6,13-14H,7-12H2,1-2H3 VOMKYFREVRKVTK-UHFFFAOYSA-N 358856 N-(2-methoxyethyl)-N-methyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 8.70 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358856&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226955 386398363 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708286 COCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-29-9-6-23-21(28)15-2-3-19-24-13-16(27(19)25-15)18-12-14-17(31-18)4-5-22-20(14)26-7-10-30-11-8-26/h2-5,12-13H,6-11H2,1H3,(H,23,28) WGGGLERYINLRRP-UHFFFAOYSA-N 358857 N-(2-methoxyethyl)-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 12.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358857&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226869 386398364 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708287 C[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-13(12-28)24-21(29)15-2-3-19-23-11-16(27(19)25-15)18-10-14-17(31-18)4-5-22-20(14)26-6-8-30-9-7-26/h2-5,10-11,13,28H,6-9,12H2,1H3,(H,24,29)/t13-/m1/s1 PVRBWFBXZIVHES-CYBMUJFWSA-N 358858 N-[(2R)-1-hydroxypropan-2-yl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 5.80 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358858&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126506660 386398365 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708288 C[C@@H](CO)NC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-13(12-28)24-21(29)15-2-3-19-23-11-16(27(19)25-15)18-10-14-17(31-18)4-5-22-20(14)26-6-8-30-9-7-26/h2-5,10-11,13,28H,6-9,12H2,1H3,(H,24,29)/t13-/m0/s1 PVRBWFBXZIVHES-ZDUSSCGKSA-N 358859 N-[(2S)-1-hydroxypropan-2-yl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 21.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358859&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226928 386398366 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708289 CN(C)CCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H27N7O3/c1-28(2)9-3-7-25-23(31)17-4-5-21-26-15-18(30(21)27-17)20-14-16-19(33-20)6-8-24-22(16)29-10-12-32-13-11-29/h4-6,8,14-15H,3,7,9-13H2,1-2H3,(H,25,31) XANSVPHMOYWUDL-UHFFFAOYSA-N 358860 N-[3-(dimethylamino)propyl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 4.50 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358860&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226903 386398367 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708290 CN(C)CCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H21N5O2/c1-24(2)11-5-10-21-20(26)15-8-9-19-22-13-16(25(19)23-15)18-12-14-6-3-4-7-17(14)27-18/h3-4,6-9,12-13H,5,10-11H2,1-2H3,(H,21,26) DDJUFZKSGQXYOQ-UHFFFAOYSA-N 358861 3-(1-Benzofuran-2-yl)-N-[3-(dimethylamino)propyl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 7.90 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358861&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226974 386398368 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708291 C[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O3/c1-11(10-23)20-18(24)13-6-7-17-19-9-14(22(17)21-13)16-8-12-4-2-3-5-15(12)25-16/h2-9,11,23H,10H2,1H3,(H,20,24)/t11-/m1/s1 CCGWYSCQCABNRE-LLVKDONJSA-N 358862 3-(1-Benzofuran-2-yl)-N-[(2R)-1-hydroxypropan-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 8.80 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358862&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126506376 386398369 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708292 COCCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O3/c1-25-10-4-9-20-19(24)14-7-8-18-21-12-15(23(18)22-14)17-11-13-5-2-3-6-16(13)26-17/h2-3,5-8,11-12H,4,9-10H2,1H3,(H,20,24) OGCODLLIZHFTLY-UHFFFAOYSA-N 358863 3-(1-Benzofuran-2-yl)-N-(3-methoxypropyl)imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 9.50 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358863&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226876 386398370 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708293 CC(C)[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-12(2)15(11-25)22-20(26)14-7-8-19-21-10-16(24(19)23-14)18-9-13-5-3-4-6-17(13)27-18/h3-10,12,15,25H,11H2,1-2H3,(H,22,26)/t15-/m0/s1 HQISLAYJOPDUTK-HNNXBMFYSA-N 358864 3-(1-Benzofuran-2-yl)-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]imidazo[1,2-b]-pyridazine-6-carboxamide::US10214545, Example 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 12.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358864&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126505992 386398371 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708294 O=C(NCc1ccccc1)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H16N4O2/c27-22(24-13-15-6-2-1-3-7-15)17-10-11-21-23-14-18(26(21)25-17)20-12-16-8-4-5-9-19(16)28-20/h1-12,14H,13H2,(H,24,27) OIHQAKBAJBCIMS-UHFFFAOYSA-N 358865 3-(1-Benzofuran-2-yl)-N-benzylimidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 12.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358865&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226966 386398372 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708295 COCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O3/c1-24-9-8-19-18(23)13-6-7-17-20-11-14(22(17)21-13)16-10-12-4-2-3-5-15(12)25-16/h2-7,10-11H,8-9H2,1H3,(H,19,23) OLVXJFKWUNVLLV-UHFFFAOYSA-N 358866 3-(1-Benzofuran-2-yl)-N-(2-methoxyethyl)imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 15.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358866&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226981 386398373 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708296 CN(Cc1ccccc1)C(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H18N4O2/c1-26(15-16-7-3-2-4-8-16)23(28)18-11-12-22-24-14-19(27(22)25-18)21-13-17-9-5-6-10-20(17)29-21/h2-14H,15H2,1H3 MOSBOQYSPFXZQT-UHFFFAOYSA-N 358867 3-(1-Benzofuran-2-yl)-N-benzyl-N-methylimidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 23.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358867&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226949 386398374 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708297 CN(C)CCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H19N5O2/c1-23(2)10-9-20-19(25)14-7-8-18-21-12-15(24(18)22-14)17-11-13-5-3-4-6-16(13)26-17/h3-8,11-12H,9-10H2,1-2H3,(H,20,25) JAFJCFZVEUTXGQ-UHFFFAOYSA-N 358868 3-(1-Benzofuran-2-yl)-N-[2-(dimethylamino)ethyl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 34.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358868&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226871 386398375 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708298 CC(C)[C@@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-12(2)15(11-25)22-20(26)14-7-8-19-21-10-16(24(19)23-14)18-9-13-5-3-4-6-17(13)27-18/h3-10,12,15,25H,11H2,1-2H3,(H,22,26)/t15-/m1/s1 HQISLAYJOPDUTK-OAHLLOKOSA-N 358869 3-(1-Benzofuran-2-yl)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]imidazo[1,2-b]-pyridazine-6-carboxamide::US10214545, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) Human 42.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U 2/26/2019 10/20/2019 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358869&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 91824175 386398376 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6